zika%20virus%20infection
ZIKA VIRUS INFECTION

Zika virus is an icosahedral, enveloped, single-stranded RNA virus that comes from the Flaviviridae family and genus Flavivirus.

It is transmitted in humans through a bite of Aedes aegypti and Aedes albopictus mosquito.

In February 2016, the Zika virus infection was declared by the World Health Organization (WHO) as an international health emergency.

Pregnant women infected by Zika virus may pass their infection to the developing fetus and may cause birth defects such as microcephaly, ventriculomegaly, intracranial calcifications, extra-axial fluid, polymicrogyria, decreased brain parenchymal volume, hypoplasia of the cerebellum, brainstem or dermis, delayed myelination, thinning or hypoplasia of the corpus callosum and cortical atrophy and malformation.

 

 

Drug Information

Indication: Relief of muscle & joint pain eg, backache, osteoarthritis, muscular aches & pains & rheumatic pai...

Indication: Relief of fever & discomfort associated w/ the common cold & flu, relief of teething pain, toothache.

Indication: Temporary relief of headache & pain & discomfort in cold & flu, rheumatic, muscular & neuralgi...

Indication: Relief of headache, fever & mild to moderate pain.

Indication: Relief of fever & discomfort associated w/ common cold & flu. Relief of mild to moderate pain eg, teet...

Indication: Symptomatic relief of fever, minor aches & pain.

Indication: Symptomatic relief of fever, mild to moderate pain. 500 mg Fever, headache, dysmenorrhea, muscle pain, arthral...

Indication: Relief of fever & mild to moderate pain.

2  /  4
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Audrey Abella, 06 Aug 2019
The guideline-recommended, single-tablet, fixed-dose regimen comprising bictegravir, emtricitabine, and tenofovir alafenamide (B/F/TAF) was noninferior to the dolutegravir and F/TAF (D/F/TAF) regimen in persons living with HIV (PLHIV), according to data presented at IAS 2019.